leisure time -WSS

leisure time

author：hotspot 2025-09-30 00:38:47 - browse：248

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： ACIP vaccine advisory panel sees its vacancies filled

knowledge

WSS

Juul documents reveal insider tactics on political lobbying

Resistance to opioid

The high cost of giving birth even with insurance

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Why Eli Lilly’s earnings didn’t quite live up to the hype

Dobbs anniversary: the lost opportunity of abortion as health care

leisure time

leisure time

explore

Novavax promises a turnaround & Lilly roils the obesity market

Peter Hotez and the public health issue of online harassment

Hepatitis C has a cure — but many Americans still lack access to it

New air purifier tech could be key to improving indoor air quality

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Cancer drug shortages should be causing more outrage

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Activists slam private health insurers over coverage restrictions

AMAs digital advisors table RPM coding reform proposal, again

focus

Guidelines to prevent youth baseball injuries need more muscle

Malaria cases in Florida and Texas: Here’s what you need to know

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Doctors on social media are being harassed and cyberbullied

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Readout Newsletter: Amylyx, Aurinia, and IQVIA

hotspot

hotspot

knowledge

knowledge